Sirnio P, Elomaa H, Tuomisto A, Aijala V, Karjalainen H, Kastinen M
Cancer Immunol Immunother. 2025; 74(4):111.
PMID: 39998677
PMC: 11861821.
DOI: 10.1007/s00262-025-03964-x.
Ramadesikan S, Colwell C, Supinger R, Hunter J, Thomas J, Varga E
Cold Spring Harb Mol Case Stud. 2023; 9(4).
PMID: 37816608
PMC: 10815271.
DOI: 10.1101/mcs.a006294.
Bacenkova D, Trebunova M, Cizkova D, Hudak R, Dosedla E, Findrik-Balogova A
Biomedicines. 2022; 10(4).
PMID: 35453654
PMC: 9029210.
DOI: 10.3390/biomedicines10040904.
Jiangang S, Nayoung K, Hongfang W, Junda L, Li C, Xuefeng B
BMC Mol Cell Biol. 2022; 23(1):19.
PMID: 35413817
PMC: 9004192.
DOI: 10.1186/s12860-022-00418-5.
Storz L, Walther P, Chemnitzer O, Lyros O, Niebisch S, Mehdorn M
Cancers (Basel). 2021; 13(11).
PMID: 34199909
PMC: 8200109.
DOI: 10.3390/cancers13112806.
Regenerative Intestinal Stem Cells Induced by Acute and Chronic Injury: The Saving Grace of the Epithelium?.
Rees W, Tandun R, Yau E, Zachos N, Steiner T
Front Cell Dev Biol. 2020; 8:583919.
PMID: 33282867
PMC: 7688923.
DOI: 10.3389/fcell.2020.583919.
MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer.
Nishiuchi A, Hisamori S, Sakaguchi M, Fukuyama K, Hoshino N, Itatani Y
Cancers (Basel). 2019; 11(12).
PMID: 31783700
PMC: 6966658.
DOI: 10.3390/cancers11121891.
Regulation of Expression and Prediction of 5-Fluorouracil Sensitivity by CDX2 in Ovarian Mucinous Carcinoma.
Koh I, Nosaka S, Sekine M, Sugimoto J, Hirata E, Kudo Y
Cancer Genomics Proteomics. 2019; 16(6):481-490.
PMID: 31659102
PMC: 6885360.
DOI: 10.21873/cgp.20151.
Barretts's carcinogenesis.
Mukaisho K, Kanai S, Kushima R, Nakayama T, Hattori T, Sugihara H
Pathol Int. 2019; 69(6):319-330.
PMID: 31290583
PMC: 6851828.
DOI: 10.1111/pin.12804.
The H2A.Z histone variant integrates Wnt signaling in intestinal epithelial homeostasis.
Rispal J, Baron L, Beaulieu J, Chevillard-Briet M, Trouche D, Escaffit F
Nat Commun. 2019; 10(1):1827.
PMID: 31015444
PMC: 6478875.
DOI: 10.1038/s41467-019-09899-z.
SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion.
Zhao Y, Zhou X, He Y, Liao C
Oncol Lett. 2018; 16(4):4977-4983.
PMID: 30250563
PMC: 6144910.
DOI: 10.3892/ol.2018.9273.
Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM.
Jin R, Mills J
Dig Dis Sci. 2018; 63(8):2028-2041.
PMID: 29948563
DOI: 10.1007/s10620-018-5150-0.
Metachronous Synchronous Sternal and Colonic Metastasis with Asymptomatic Colo-colic Fistula from Carcinoma Ovary Rare Presentation of Ovarian Cancer.
K G S, Mirza A, Swamy S, S A, Ks G
Indian J Surg Oncol. 2017; 8(4):615-618.
PMID: 29203996
PMC: 5705497.
DOI: 10.1007/s13193-016-0576-3.
Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
Souza R
J Gastroenterol. 2017; 52(7):767-776.
PMID: 28451845
PMC: 5488728.
DOI: 10.1007/s00535-017-1342-1.
Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
Huo X, Zhang X, Yu C, Cheng E, Zhang Q, Dunbar K
Gut. 2017; 67(4):606-615.
PMID: 28442495
PMC: 5656558.
DOI: 10.1136/gutjnl-2016-313584.
CDX2 increases SLC7A7 expression and proliferation of pig intestinal epithelial cells.
Li X, Xu G, Zhai Z, Gao C, Yan H, Xi Q
Oncotarget. 2016; 7(21):30597-609.
PMID: 27121315
PMC: 5058704.
DOI: 10.18632/oncotarget.8894.
Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
Koh I, Hinoi T, Sentani K, Hirata E, Nosaka S, Niitsu H
Cancer Med. 2016; 5(7):1546-55.
PMID: 27060927
PMC: 4944882.
DOI: 10.1002/cam4.697.
Spatiotemporal distribution of caudal-type homeobox proteins during development of the hindgut and anorectum in human embryos.
Tang X, Zhang T, Wang W, Yuan Z, Bai Y
PeerJ. 2016; 4:e1771.
PMID: 27042391
PMC: 4811170.
DOI: 10.7717/peerj.1771.
Temporal and spatial expression of caudal-type homeobox proteins in the midgut of human embryos.
Tang X, Zhang J, Wang W, Yuan Z, Bai Y
Int J Clin Exp Med. 2016; 8(11):19895-904.
PMID: 26884902
PMC: 4723747.
Premalignant lesions in gastric cancer.
Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K, Murawaki Y
Clin J Gastroenterol. 2015; 3(1):6-12.
PMID: 26189899
DOI: 10.1007/s12328-009-0130-8.